Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avalo Therapeutics (AVTX) Change in Inventory (2017 - 2023)

Historic Change in Inventory for Avalo Therapeutics (AVTX) over the last 7 years, with Q3 2023 value amounting to -$18000.0.

  • Avalo Therapeutics' Change in Inventory fell 170000.0% to -$18000.0 in Q3 2023 from the same period last year, while for Jun 2024 it was -$18000.0, marking a year-over-year decrease of 26000.0%. This contributed to the annual value of -$20000.0 for FY2023, which is 1111.11% down from last year.
  • Per Avalo Therapeutics' latest filing, its Change in Inventory stood at -$18000.0 for Q3 2023, which was down 170000.0% from -$1000.0 recorded in Q2 2023.
  • In the past 5 years, Avalo Therapeutics' Change in Inventory ranged from a high of $68294.0 in Q4 2019 and a low of -$411736.0 during Q2 2019
  • In the last 5 years, Avalo Therapeutics' Change in Inventory had a median value of -$3000.0 in 2020 and averaged -$29155.1.
  • Its Change in Inventory has fluctuated over the past 5 years, first surged by 60000.0% in 2021, then crashed by 170000.0% in 2023.
  • Avalo Therapeutics' Change in Inventory (Quarter) stood at $68294.0 in 2019, then plummeted by 108.79% to -$6000.0 in 2020, then surged by 466.67% to $22000.0 in 2021, then crashed by 109.09% to -$2000.0 in 2022, then tumbled by 800.0% to -$18000.0 in 2023.
  • Its Change in Inventory was -$18000.0 in Q3 2023, compared to -$1000.0 in Q2 2023 and -$1000.0 in Q1 2023.